EVALUATION OF KUCHLA (NUX VOMICA) IN DIABETIC NEUROPATHY
Swatika*, Om Prakash Sharma, Naresh Kumar Garg, Nikita Panwar and Monika
Abstract
Diabetic neuropathy (DN) refers to symptoms and signs of neuropathy
in a patient with diabetes in whom other causes of neuropathy have
been excluded. Distal symmetrical neuropathy is the commonest
accounting for 75% DN. Asymmetrical neuropathies may involve
cranial nerves, thoracic or limb nerves; are of acute onset resulting
from ischemic infarction of vasa nervosa. Asymmetric neuropathies in
diabetic patients should be investigated for entrapment neuropathy.
Diabetic amyotrophic, initially considered to result from metabolic
changes, and later ischemia, is now attributed to immunological
changes. For diagnosis of DN, symptoms, signs, quantitative sensory
testing, nerve conduction study, and autonomic testing are used; and
two of these five are recommended for clinical diagnosis. Management of DN includes
control of hyperglycemia, other cardiovascular risk factors; α lipoic acid and L carnitine. For
neuropathic pain, analgesics, non‐steroidal anti‐inflammatory drugs, antidepressants, and
anticonvulsants are recommended. The treatment of autonomic neuropathy is symptomatic.
Keywords: Neuropathy, Diabetes, Treatment, Classification, Kuchla, Nux vomica.
[Full Text Article]